Immediate Impact
64 standout
Citing Papers
GPCR drug discovery: new agents, targets and indications
2025 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Huma U. Sheikh being referenced
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations
2022
The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the U nited S tates: A Review of Statistics From National Surveillance Studies
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Huma U. Sheikh | 427 | 172 | 69 | 89 | 16 | 529 | |
| Stephen Loder | 380 | 171 | 41 | 80 | 7 | 523 | |
| Steven M. Baskin | 490 | 175 | 29 | 143 | 19 | 548 | |
| Shiang‐Ru Lu | 422 | 210 | 74 | 144 | 22 | 635 | |
| Neel Shah | 311 | 161 | 79 | 65 | 19 | 514 | |
| Olivia Begasse de Dhaem | 430 | 152 | 48 | 87 | 24 | 498 | |
| Hallie Thomas | 478 | 247 | 69 | 101 | 22 | 644 | |
| Rachel Hering‐Hanit | 316 | 167 | 52 | 133 | 19 | 459 | |
| Kaname Ueda | 466 | 203 | 37 | 76 | 23 | 590 | |
| L Savi | 347 | 126 | 34 | 121 | 32 | 486 | |
| Florindo d’Onofrio | 460 | 213 | 74 | 136 | 24 | 553 |
All Works
Loading papers...